Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.
BACKGROUND
Excessive exposure to dietary fats is an important factor in the initiation of obesity and metabolic syndrome associated pathologies. The cellular processes associated with the onset and progression of diet-induced metabolic syndrome are insufficiently understood.


RESULTS
To identify the mechanisms underlying the pathological changes associated with short and long-term exposure to excess dietary fat, hepatic gene expression of ApoE3Leiden mice fed chow and two types of high-fat (HF) diets was monitored using microarrays during a 16-week period. A functional characterization of 1663 HF-responsive genes reveals perturbations in lipid, cholesterol and oxidative metabolism, immune and inflammatory responses and stress-related pathways. The major changes in gene expression take place during the early (day 3) and late (week 12) phases of HF feeding. This is also associated with characteristic opposite regulation of many HF-affected pathways between these two phases. The most prominent switch occurs in the expression of inflammatory/immune pathways (early activation, late repression) and lipogenic/adipogenic pathways (early repression, late activation). Transcriptional network analysis identifies NF-kappaB, NEMO, Akt, PPARgamma and SREBP1 as the key controllers of these processes and suggests that direct regulatory interactions between these factors may govern the transition from early (stressed, inflammatory) to late (pathological, steatotic) hepatic adaptation to HF feeding. This transition observed by hepatic gene expression analysis is confirmed by expression of inflammatory proteins in plasma and the late increase in hepatic triglyceride content. In addition, the genes most predictive of fat accumulation in liver during 16-week high-fat feeding period are uncovered by regression analysis of hepatic gene expression and triglyceride levels.


CONCLUSIONS
The transition from an inflammatory to a steatotic transcriptional program, possibly driven by the reciprocal activation of NF-kappaB and PPARgamma regulators, emerges as the principal signature of the hepatic adaptation to excess dietary fat. These findings may be of essential interest for devising new strategies aiming to prevent the progression of high-fat diet induced pathologies.
Radonjic
Marijana
M
Nutrigenomics Consortium, Top Institute Food and Nutrition, Wageningen, The Netherlands. marijana.radonjic@tno.nl
de Haan
Jorn R
JR
van Erk
Marjan J
MJ
van Dijk
Ko Willems
KW
van den Berg
Sjoerd A A
SA
de Groot
Philip J
PJ
Müller
Michael
M
van Ommen
Ben
B
D000222:Adaptation, Physiological; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D004041:Dietary Fats / Q000008:administration & dosage*; D005234:Fatty Liver / Q000235:genetics* / Q000503:physiopathology; D016678:Genome; D008099:Liver / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D012333:RNA, Messenger / Q000235:genetics*; D014158:Transcription, Genetic; D014280:Triglycerides / Q000097:blood
D001798:Blood Proteins; D004041:Dietary Fats; D012333:RNA, Messenger; D014280:Triglycerides
J Neuroimmunol. 1995 Dec 31;63(2):157-62
8550813
J Clin Invest. 1974 Jan;53(1):64-76
4357617
Nucleic Acids Res. 2005 Nov 10;33(20):e175
16284200
Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):365-71
11231915
Biochim Biophys Acta. 2007 Aug;1771(8):926-35
17433773
Biochem Biophys Res Commun. 2005 Oct 14;336(1):215-22
16125673
J Clin Invest. 2006 Jul;116(7):1793-801
16823477
J Clin Invest. 1994 Apr;93(4):1403-10
8163645
Intern Med. 2007;46(19):1633-9
17917325
Cell. 1996 Nov 1;87(3):377-89
8898192
Nat Cell Biol. 2003 Mar;5(3):224-30
12598905
Nature. 2006 Dec 14;444(7121):860-7
17167474
J Clin Invest. 1999 Aug;104(4):383-9
10449430
Atherosclerosis. 1999 Mar;143(1):15-25
10208477
Nat Med. 2005 Feb;11(2):183-90
15685173
Nucleic Acids Res. 2006 Mar 01;34(4):1261-9
16510852
Cell Death Differ. 2003 Jan;10(1):45-65
12655295
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1984-90
11742874
Bioinformatics. 2004 Jun 12;20(9):1453-4
14871861
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):145-56
17237841
Genome Biol. 2007;8(9):R200
17892536
Obesity (Silver Spring). 2007 Apr;15(4):798-808
17426312
Gut. 2004 Jul;53(7):1044-53
15194659
J Biol Chem. 1995 Jun 2;270(22):12953-6
7768881
Gastroenterology. 2007 May;132(6):2087-102
17498505
Br J Dermatol. 2003 Aug;149(2):229-36
12932225
Circulation. 2004 Jan 27;109(3):393-8
14699006
Nat Genet. 2006 May;38(5):500-1
16642009
J Biol Chem. 1993 May 15;268(14):10540-5
7683682
Circulation. 2002 Aug 6;106(6):679-84
12163427
Eur J Clin Nutr. 1995 Feb;49(2):79-90
7743988
Cell Metab. 2008 Apr;7(4):302-11
18396136
Nature. 2008 Jul 24;454(7203):428-35
18650913
Cell. 1998 Jun 26;93(7):1231-40
9657155
Blood. 2003 Apr 15;101(8):3058-64
12480693
J Clin Invest. 2004 Jul;114(2):147-52
15254578
J Immunol. 2003 Dec 15;171(12):6827-37
14662889
Genome Biol. 2003;4(5):P3
12734009
J Biol Chem. 2003 Sep 5;278(36):34268-76
12805374
J Virol. 2008 May;82(9):4250-6
18287226
Vet Pathol. 2009 May;46(3):491-504
19176496
J Biol Chem. 2002 Aug 16;277(33):29674-80
12052823
Trends Immunol. 2007 Dec;28(12):551-8
17981503
J Lipid Res. 2005 May;46(5):988-93
15716584
Cancer Cell. 2007 Feb;11(2):119-32
17292824
BMC Bioinformatics. 2006 Jan 06;7:3
16398926
Atherosclerosis. 2005 Oct;182(2):249-57
16159597
J Immunol. 1997 Oct 1;159(7):3474-82
9317146
Nature. 1999 Sep 2;401(6748):86-90
10485711
J Biol Chem. 1999 Nov 5;274(45):32048-54
10542237
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
16199517
J Biol Chem. 2004 Aug 13;279(33):35017-24
15180999
Nature. 2000 Jan 6;403(6765):103-8
10638762
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
9843981
Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1297-302
18216263
Cell. 2007 Jun 29;129(7):1261-74
17604717
Nature. 2008 Jul 24;454(7203):470-7
18650918
Nature. 1999 Sep 2;401(6748):82-5
10485710
Clin Chem Lab Med. 2005;43(5):470-9
15899668
Nat Rev Genet. 2003 Apr;4(4):315-22
12671662
Crit Care Med. 2008 Sep;36(9):2576-82
18679128
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4844-9
10781090
Int J Obes Relat Metab Disord. 2000 May;24(5):639-46
10849588
Genes Dev. 1996 May 1;10(9):1096-107
8654925
J Biol Chem. 2003 Jan 3;278(1):498-505
12401792
J Clin Invest. 2005 May;115(5):1111-9
15864338
Bioinformatics. 2006 Aug 15;22(16):2028-36
16809386
Biochim Biophys Acta. 1996 Nov 15;1317(2):84-94
8950192
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
Am J Respir Cell Mol Biol. 2002 Mar;26(3):315-32
11867340
Eur J Clin Invest. 2008 Jul;38(7):510-5
18489583
Hepatology. 2006 Aug;44(2):420-9
16871591
J Biol Chem. 1999 Sep 24;274(39):27339-42
10488062
Cell Mol Biol (Noisy-le-grand). 2002 Feb;48(1):103-10
11929041
J Clin Invest. 2000 Aug;106(4):523-31
10953027
Nature. 2000 Apr 6;404(6778):635-43
10766250